References
- Hennekens CH , DeMets D . Statistical association and causation: Contributions of different types of evidence. JAMA 2011;306:1134-6
- Selkoe DJ . Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 2001;81:741-66
- Friedrich MJ . Researchers test strategies to prevent Alzheimer disease. JAMA 2014;311(16):1596-8
- Extance A . Alzheimer’s failure raises questions about disease-modifying strategies. Nat Rev Drug Discov 2010;9:749-51
- Green RC , Schneider LS , Amato DA . Effect of tarenflurbil on cognitive decline and activities of daily living in partients with mild Alzheimer disease: a randomised controlled trial. JAMA 2009;302:2557-64
- Jack CR Jr , Knopman DS , Jagust WJ , et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 2010;9:119-28
- George DR , Whitehouse PJ . Chasing the white whale of Alzheimer’s. JAGS 2014;62(3):588-9
- Puzzo D , Arancio O . Amyloid-beta Peptide: Dr. Jekyll or Mr. Hyde? J Alzheimers Dis 2013;33(Suppl 1):S111-20
- McGowan E , Pickford F , Kim J , et al. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 2005;47:191-9
- Bien J , Jefferson T , Causevic M , et al. The metalloprotease meprin beta generates amino terminal-truncated amyloid beta peptide species. J Biol Chem 2012;287:33304-13
- Mawuenyega KG , Sigurdson W , Ovod V , et al. Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 2010;330:1774
- Jawhar S , Wirths O , Bayer TA . Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease. J Biol Chem 2011;286:38825-32
- Nussbaum JM , Schilling S , Cynis H , et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta. Nature 2012;485:651-5
- Schilling S , Zeitschel U , Hoffmann T , et al. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology. Nat Med 2008;14:1106-11
- Frost JL , Liu B , Kleinschmidt M , et al. Passive immunization against pyroglutamate-3 amyloid-beta reduces plaque burden in Alzheimer-like transgenic mice: a pilot study. Neurodegener Dis 2012;10:265-70
- Seifert F , Schulz K , Koch B , et al. Glutaminyl cyclases display significant catalytic proficiency for glutamyl Substrates. Biochemistry 2009;48:11831-3